This is the authors' abstract. We don't add key points for this paper.
Machine learning is revolutionizing protein design by enabling the rapid generation of sequences with precise structural and functional properties. Controlling protein conformational states remains a major challenge, particularly for enzymes regulated by complex structural switches. Here, using high-resolution structural data and probabilistic sequence-structure models, a machine learning-driven framework for conformationally biased protein design is presented titled Conformation-Specific Design or CSDesign. This approach generates sequences predicted to favor a desired conformation while disfavoring alternative states. As a proof-of-concept, this approach is applied to extracellular signal-regulated kinase 2 (ERK2), generating variants predicted to favor the active or inactive state. Experimental validation of relative kinase activity in a controlled assay confirmed that an active-biased variant, CSD104, exhibits robust kinase activity without native upstream phosphorylation, while an inactive-biased variant, CSD101, remains inactivated. Structural analysis suggests that engineered interactions stabilize active-like features in place of phosphorylation. These results demonstrate machine learning control of protein conformational ensembles, with potential to design enzymes and other conformationally regulated proteins without relying on phosphomimetic mutations or extensive experimental screening.
No takes yet. Share an insight, caveat, or question.
Talley et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: